JP Patent
JP6696082B2 — Mpges−1阻害剤を含むナノ粒子製剤
Assigned to イクノス サイエンシズ エスエー · Expires 2020-05-20 · 6y expired
What this patent protects
Patent listed against Emend.
Drugs covered by this patent
- Emend (APREPITANT) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.